Fig. 1From: Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomographyStudy flow chart. We enrolled 50 patients who were treated using everolimus-eluting stent [37 lesions in 29 patients with diabetes mellitus (DM) and 23 lesions in 21 patients without DM] and 23 lesions in 21 patients without DM). PCI: percutaneous coronary intervention; CGM: continuous glucose monitoring; VH-IVUS: virtual histology intravascular ultrasound; IGT: impaired glucose tolerance; NGT: normal glucose tolerance; OCT: optical coherence tomography Back to article page